Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Cash Flows (Unaudited)

v3.20.2
Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities    
Loss for the period $ (19,518) $ (1,606)
Adjustments to reconcile net loss to net cash used in operating activities    
Amortization of intangible assets 1 3
In-process research and development 16,094  
Amortization of deferred loan costs 27  
Interest expense 8  
Shares issued for services   5
Warrants issued for services 45  
Stock option expense 405 51
Changes in operating assets and liabilities    
Prepaid expenses and deposits 24 56
Interest, taxes and other receivables   (44)
Accounts payable and accrued liabilities (914) (617)
Related party payables (282) (114)
Net cash used in operating activities (4,110) (2,266)
Cash flows from investing activities    
Cash acquired on merger with Adgero 969  
Net cash provided by investing activities 969  
Cash flows from financing activities    
Net proceeds from the issuance of shares and warrants 21,859 6,583
Warrants exercised for cash 994 26
Proceeds from loan 500  
Series A preferred cash dividend (2) (2)
Net cash provided by financing activities 23,351 6,607
Decrease in cash and cash equivalents 20,210 4,341
Cash and cash equivalents – beginning of period 2,392 3,719
Cash and cash equivalents – end of period $ 22,602 $ 8,060